Ratings by Alliance Global Partners (Benjamin Haynor)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/19/2022 | Heska Corp. | HSKA | Maintain | Buy (N/A) |
|
Details | ||
| 9/14/2021 | Itamar Medical | ITMR | Downgrade | Neutral (Buy) |
30.25 (30.87) |
2.05% | Details | |
| 8/4/2021 | Heska Corp. | HSKA | Maintain | Buy (N/A) |
|
Details | ||
| 8/11/2020 | iBio, Inc. | IBIO | Maintain | Buy (N/A) |
|
Details | ||
| 8/10/2020 | Sensus Healthcare | SRTS | Upgrade | Buy (Neutral) |
3.00 (4.28) |
42.67% | Details | |
| 8/5/2020 | Heska Corp. | HSKA | Maintain | Buy (N/A) |
|
Details | ||
| 5/6/2020 | Sensus Healthcare | SRTS | Downgrade | Neutral (Buy) |
2.60 (4.25) |
63.46% | Details | |
| 2/14/2020 | Sensus Healthcare | SRTS | Upgrade | Buy (Neutral) |
4.62 (2.60) |
-43.72% | Details | |
| 1/23/2020 | T2 Biosystems, Inc | TTOO | Upgrade | Buy (Neutral) |
1.17 (0.13) |
-88.89% | Details | |
| 8/29/2019 | Itamar Medical | ITMR | New Coverage | Buy (N/A) |
8.80 (30.25) |
243.75% | Details | |
| 8/1/2019 | T2 Biosystems, Inc | TTOO | Downgrade | Neutral (Buy) |
0.59 (1.17) |
98.31% | Details | |
| 6/20/2019 | Precipio | PRPO | New Coverage | Buy (N/A) |
3.15 (26.53) |
742.22% | Details | |
| 5/16/2019 | T2 Biosystems, Inc | TTOO | New Coverage | Buy (N/A) |
2.62 (0.59) |
-77.48% | Details |
